GSK5471713 clinical trials

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

This study is testing a new medicine, GSK5471713, for men with advanced prostate cancer that has spread and isn't responding to other treatments. It aims to see if the medicine is safe, what effects it has, and if it helps patients. This is early research to understand its potential.